BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19822089)

  • 1. Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice.
    De Steenwinkel JE; De Knegt GJ; Ten Kate MT; Van Belkum A; Verbrugh HA; Hernandez-Pando R; Van Soolingen D; Bakker-Woudenberg IA
    Int J Immunopathol Pharmacol; 2009; 22(3):723-34. PubMed ID: 19822089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice.
    Beamer GL; Flaherty DK; Vesosky B; Turner J
    Clin Vaccine Immunol; 2008 Mar; 15(3):474-83. PubMed ID: 18184822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
    de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.
    Waruk JL; Machuki Z; Mesa C; Juno JA; Anzala O; Sharma M; Ball TB; Oyugi J; Kiazyk S
    Tuberculosis (Edinb); 2015 Sep; 95(5):555-61. PubMed ID: 26073895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of tuberculosis versus primary tuberculosis; course, pathogenesis and therapy in mice.
    de Steenwinkel JE; de Knegt GJ; ten Kate MT; Verbrugh HA; Hernandez-Pando R; Leenen PJ; Bakker-Woudenberg IA
    Tuberculosis (Edinb); 2013 Mar; 93(2):213-21. PubMed ID: 23266260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
    Kondratieva TK; Kapina MA; Rubakova EI; Kondratieva EV; Nikonenko BV; Majorov KB; Dyatlov AV; Linge IA; Apt AS
    Tuberculosis (Edinb); 2018 Dec; 113():130-138. PubMed ID: 30514495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study on immune adjunctive therapy for multidrug-resistant Mycobacterium tuberculosis infection in animal models].
    Hou JH; Li Q; Lu Y; Zheng MQ; Zhao WJ; Xu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Dec; 35(12):911-4. PubMed ID: 23328182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice.
    Beamer GL; Flaherty DK; Assogba BD; Stromberg P; Gonzalez-Juarrero M; de Waal Malefyt R; Vesosky B; Turner J
    J Immunol; 2008 Oct; 181(8):5545-50. PubMed ID: 18832712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoendocrine abnormalities in the male reproductive system during experimental pulmonary tuberculosis.
    Ramos Robles B; Valdez RA; Hernández UJ; Marquina Castillo B; Mata Espinosa D; Barrios Payan J; Hernández Pando R; Romano MC
    Tuberculosis (Edinb); 2018 Mar; 109():109-116. PubMed ID: 29559114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
    Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.
    Jayakumar A; Vittinghoff E; Segal MR; MacKenzie WR; Johnson JL; Gitta P; Saukkonen J; Anderson J; Weiner M; Engle M; Yoon C; Kato-Maeda M; Nahid P;
    Tuberculosis (Edinb); 2015 Jul; 95(4):415-20. PubMed ID: 26022314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender biased immune-biomarkers in active tuberculosis and correlation of their profiles to efficacy of therapy.
    Chavez K; Ravindran R; Dehnad A; Khan IH
    Tuberculosis (Edinb); 2016 Jul; 99():17-24. PubMed ID: 27450000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.
    Happel KI; Lockhart EA; Mason CM; Porretta E; Keoshkerian E; Odden AR; Nelson S; Ramsay AJ
    Infect Immun; 2005 Sep; 73(9):5782-8. PubMed ID: 16113296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils exacerbate tuberculosis infection in genetically susceptible mice.
    Yeremeev V; Linge I; Kondratieva T; Apt A
    Tuberculosis (Edinb); 2015 Jul; 95(4):447-51. PubMed ID: 25935122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome.
    Marino S; Gideon HP; Gong C; Mankad S; McCrone JT; Lin PL; Linderman JJ; Flynn JL; Kirschner DE
    PLoS Comput Biol; 2016 Apr; 12(4):e1004804. PubMed ID: 27065304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.